TORONTO, March 26, 2024 /CNW/ - DRI Healthcare Trust (TSX:
DHT.UN) ( TSX: DHT.U) ("DRI" or the "Trust"), a global leader in
providing financing to advance innovation in the life sciences
industry, today announced that the Trust will participate in the
following investor conferences in April and May:
2024 Bloom Burton & Co.
Healthcare Investor Conference
Date: April 17, 2024
Presentation time: 10:30 am ET
City: Toronto, Ontario
Event URL: https://www.bloomburton.com/conference/
2024 RBC Capital Markets Global
Healthcare Conference
Date: May 14, 2024
Presentation time: 9:30 am ET
City: New York, New York
Event URL:
https://web.cvent.com/event/ccf0ab90-9cd0-4500-a3b5-cc5ce4b14445/summary?Refid=PClink&locale=en-US&rt=IHUld_2cQkOff-B0ExzbYw
About DRI Healthcare
Trust
DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI
Capital"), the pioneer in global pharmaceutical royalty
monetization with a more than 30-year history of accelerating
innovation by providing capital to inventors, academic institutions
and biopharma companies. Since its founding in 1989, DRI Capital
has deployed more than US$3.0
billion, acquiring more than 70 royalties on 45-plus drugs,
including Eylea, Keytruda, Orserdu, Spinraza, Stelara,
Vonjo, Zejula and Zytiga. DRI Healthcare Trust's units are
listed and traded on the Toronto Stock Exchange in Canadian dollars
under the symbol "DHT.UN" and in US dollars under the symbol
"DHT.U". To learn more, visit drihealthcare.com or follow us on
LinkedIn.
SOURCE DRI Healthcare Trust